Vicky Whittemore - Concepedia

Author

Vicky Whittemore

Also Known As

Dr. Vicky Holets Whittemore, P. Curtalolo, V Whittemore, Vicky H Whittemore, Vicky H. Whittemore, Vicky Holets Whittemore, Vicky Whittemore

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Neurological Disorders and Stroke Cincinnati Children's Hospital Medical Center Boston Children's Hospital Harvard University

About

Vicky Whittemore is an author at National Institutes of Health specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	2.3K
2	Education	1	1	15
3	Engineering	1	1	22
4	Health Sciences	1	1	40
5	Public Health	1	1	48

Vicky Whittemore

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference Hope Northrup, Darcy A. Krueger, Hope Northrup, Pediatric Neurology	2013	1.5K
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska, The Lancet Tuberous Sclerosis ComplexSporadic LymphangioleiomyomatosisPathologyPlacebo-controlled TrialScleroderma	2013	863
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference Darcy A. Krueger, Hope Northrup, Hope Northrup, Pediatric Neurology	2013	834
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial David Neal Franz, Steven Sparagana, E. Martina Bebin, The Lancet Tuberous Sclerosis ComplexNeuro-oncologyPlacebo-controlled Phase 3PathologySubependymal Giant Cell	2012	771
Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist Petrus J. de Vries, Vicky Whittemore, Loren Leclezio, Pediatric Neurology PsychiatryNeurological DisorderMotor DisorderNeurologyNeuroscience	2014	355
Pilot Validation of the Tuberous Sclerosis-Associated Neuropsychiatric Disorders (TAND) Checklist Loren Leclezio, Anna Jansen, Vicky Whittemore, Pediatric Neurology	2014	143
Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders Darcy A. Krueger, Anjali Sadhwani, Anna W. Byars, Annals of Clinical and Translational Neurology	2017	131
<i>SCN8A</i> encephalopathy: Research progress and prospects Miriam H. Meisler, Guy Helman, Michael F. Hammer, Epilepsia	2016	130
Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice Dan Ehninger, Yoshitake Sano, Petrus J. de Vries, Molecular Psychiatry Maternal ImmunizationFetal SurvivalDevelopmental BiologyAutoimmune DiseaseImmune Cell Development	2010	114
The Sudden Death in the Young Case Registry: Collaborating to Understand and Reduce Mortality Kristin M. Burns, Lauren Bienemann, Lena Camperlengo, PEDIATRICS Young Case RegistryFamily MembersSudden DeathCase SeriesForensic Medicine	2017	48

Page 1